Member Profile Join & Renew

ADLM 2026 education

ADLM 2026 highlights

Please find select ADLM 2026 sessions and activities below.

Scientific sessions - DEI and Health equity

Roundtable

Special event

Scientific sessions - MLS, DCLS related

For more MLS and DCLS related content, please check the MLS Day page for more insights. 

ADLM 2025 highlights

Plenary sessions

  • Sunday, July 27 Global strategies to advance genomic medicine
    Heidi Rehm, PhD, FACMG

Scientific sessions

Roundtables*

ADLM 2024 highlights

Please find select DEI related scientific sessions from ADLM 2024 below: 

Plenary sessions

  • Tuesday, July 30 Empowering Choice by Providing More Options in HIV Prevention
    Sharon L. Hillier, PhD
  • Thursday, August 1:Projected Health and Social Consequences of Ending the Federal Protection for Abortion in the United States
    Diana Greene Foster, PhD (she/her/hers)

Scientific sessions

Roundtables*

FairLabs Data Analytics Challenge

The third annual ADLM data analytics competition is cohosted by ADLM's Data Analytics Steering Committee, Health Equity & Access Division, and Informatics Division, and by the Washington University Section of Pathology Informatics. A representative of the winning team will be invited to speak at ADLM 2024 with travel support and free meeting registration included. The competition ends on May 15, 2024. The winners will be announced on July 29, 2024 at ADLM 2024.

For more on ADLM 2024, visit meeting.myadlm.org

2023 Annual Meeting DEI and Health Equity education

Please find select DEI related scientific sessions from the 2023 Annual Meeting below:

13001 Choosing Equity in Healthcare: An Organizational Transformation

(watch the recording)

The session highlights the reckoning of racism in America in 2020, and its intersectional impact on health, healthcare delivery, and medical education. An example of one academic healthcare system's approach to an enterprise-wide transformation toward organizational equity is presented. The session shares an evolution, interventions, and early outcomes as a result of the process.

Learning Objectives

At the end of this activity, participants will be able to:

  • Identify barriers to equity in healthcare.
  • Describe examples of inequity that are easy to miss and why.
  • Articulate examples of opportunities for transformation to equitable healthcare delivery.

Contributors

  • Moderator: Allan Jaffe MD, Mayo Clinic
  • Speaker: Thea James MD, MPH, MBA, Boston Medical Center

14001 Cardiovascular Disease in Women: Epidemiology, Awareness, Access, and Delivery of Equitable Health Care

(watch the recording)

Cardiovascular disease (CVD) remains the leading cause of mortality for US women. Research has identified important biologic differences between women and men and their responses to social, environmental, and behavioral stresses. Underrepresentation of women in all aspects of biologic research has delayed translation of these discoveries to women. Pervasive gaps in knowledge and care delivery require urgent attention to reduce sex-based disparities and achieve equity. Awareness campaigns must identify CVD as the major health threat for women, emphasizing the benefits of prevention in that 80–90% of CVD is preventable Advocacy is needed for public policy and legislative interventions that focus on the social determinants of health. A cultural shift is needed when presenting cardiovascular health data to the public and to health professionals that identify characteristics in men as the implicit “gold standard” with presentations in women termed “atypical.” These presentations are typical for women.

Learning Objectives

At the end of this activity, participants will be able to:

  • State the differential impact of traditional cardiovascular risk factors in men and women.
  • List cardiovascular risk factors specific to women and predominant in women.

Faculty

  • Moderator: Allan Jaffe MD, Mayo Clinic
  • Speaker: Nanette Wenger MD, MACC, MACP, FAHA, Emory University School of Medicine

32228 Stronger Together: Eliminating Racial Healthcare Inequities by Mitigating Systemic Racism

(watch the recording)

Racism is a key driver of heath inequities. Specifically, structural racism influences social determinants of health, which leads to poorer health and well-being in racial and ethnic minorities. How can laboratorians equip themselves to address this complex health dilemma? This session will provide foundational and up-to-date information to empower participants to identify the health impacts of structural racism, mitigate these impacts and achieve health equity through laboratory medicine clinical practice workflows. The interactive session will: 1) discuss the new recommendations from the AACC and National Kidney Foundation Guidance Document on Chronic Kidney Disease Diagnosis- Improving Equity in Chronic Kidney Disease; 2) review the US Preventative Services Task Force policies aimed at mitigating systemic racism in guideline development and clinical preventive services; and 3) demonstrate how laboratorians can develop a health equity framework to practice laboratory medicine across their healthcare system.

Learning objectives

At the end of this activity, participants will be able to:

  • List how structural racism impacts health.
  • Identify and describe racism and bias embedded within commonly used medical guidelines and clinical algorithms.
  • Design and implement clinical and research practice workflows that can mitigate the impacts of structural racism.

Faculty

  • Christina Pierre, PhD, DABCC
    Lancaster General Hospital
  • Esa Davis MD, MPH, FAAFP
    University of Pittsburgh Medical Center
  • Octavia Peck Palmer, PhD, FADLM
    University of Pittsburgh Medical Center

*Roundtables, University Courses, and Special Events are an additional fee and not covered under ADLM Full Conference Registration

90 Pediatric & Maternal-Fetal, Health Equity & Access, and Stewardship & Management Science Divisions Members Mixer